In this observational study, we found that patients with newly diagnosed T2D with higher serum ErbB2 concentrations exhibited increased glycemic variations with respect to MAGE, SD, and CV% than did the patients with lower serum ErbB2 concentrations. This evidence concerns the gene ERBB2 and type 2 diabetes mellitus.